Zobrazeno 1 - 10
of 187
pro vyhledávání: '"Phillip, Jeffrey"'
Autor:
Reglero, Carlos
Publikováno v:
Speculum, 2018 Jan 01. 93(1), 220-221.
Externí odkaz:
https://www.jstor.org/stable/26583762
Autor:
Katherine U. Gaynor, Marina Vaysburd, Maximilian A. J. Harman, Anna Albecka, Phillip Jeffrey, Paul Beswick, Guido Papa, Liuhong Chen, Donna Mallery, Brian McGuinness, Katerine Van Rietschoten, Steven Stanway, Paul Brear, Aleksei Lulla, Katarzyna Ciazynska, Veronica T. Chang, Jo Sharp, Megan Neary, Helen Box, Jo Herriott, Edyta Kijak, Lee Tatham, Eleanor G. Bentley, Parul Sharma, Adam Kirby, Ximeng Han, James P. Stewart, Andrew Owen, John A. G. Briggs, Marko Hyvönen, Michael J. Skynner, Leo C. James
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-15 (2023)
Abstract COVID-19 has stimulated the rapid development of new antibody and small molecule therapeutics to inhibit SARS-CoV-2 infection. Here we describe a third antiviral modality that combines the drug-like advantages of both. Bicycles are entropica
Externí odkaz:
https://doaj.org/article/83eee9acaa674188b99a7694be9c0c15
Autor:
Carlos Reglero
Publikováno v:
Speculum. 93:220-221
Autor:
Guilbeau, Phillip Jeffrey
Publikováno v:
Studies in Iconography, 2006 Jan 01. 27, 77-102.
Externí odkaz:
https://www.jstor.org/stable/23923694
Autor:
Catherine Gowland, Gareth J. Veal, Philip Berry, Phillip Jeffrey, Marc Pittman, Andrew Niewiarowski, Julie Errington, Lisa Godfrey, Stefan Symeonides, Gavin Bennett
Publikováno v:
Gowland, C, Berry, P, Errington, J, Jeffrey, P, Bennett, G, Godfrey, L, Pittman, M, Niewiarowski, A, Symeonides, S N & J Veal, G 2021, ' Development of a LC-MS/MS method for the quantification of toxic payload DM1 cleaved from BT1718 in a Phase I study ', Bioanalysis . https://doi.org/10.4155/bio-2020-0256
Background: BT1718 is a novel bicyclic peptide anticancer drug targeting membrane type I matrix metalloproteinase to release its toxic payload DM1. A LC–MS/MS method was validated to quantify DM1 generated from BT1718 in a Phase I/IIa clinical tria
Autor:
Rose, Ashley, Phillip, Jeffrey
Publikováno v:
Good Housekeeping. Mar2018, Vol. 266 Issue 3, p36-39. 4p. 8 Color Photographs.
Autor:
PHILLIP, JEFFREY
Publikováno v:
Good Housekeeping. Mar2017, Vol. 264 Issue 3, p47-52B. 5p. 20 Color Photographs.
Autor:
FORTÉ, CAROLYN, PHILLIP, JEFFREY
Publikováno v:
Good Housekeeping. Mar2016, Vol. 262 Issue 3, p46-53. 8p. 24 Color Photographs.
Publikováno v:
British Journal of Clinical Pharmacology. 74:1033-1044
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • The microdose administration of novel drug candidates to humans in early development is currently undergoing evaluation as a cost-efficient approach to the early assessment of pharmacokinetics (PK) before
Autor:
Emma J. Roberts, Peter Ernest Soden, Ruud Delwel, Dave Lugo, Brian J. P. Huntly, Samuel Robson, Olivier Mirguet, Chun-wa Chung, Soren Beinke, Rab K. Prinjha, Mikhail M. Savitski, Trevor D. Chapman, Carola Huthmacher, Emma Gudgin, Alan Kenneth Burnett, Gerard Drewes, Mark A. Dawson, Tony Kouzarides, Wai-In Chan, Konstanze Doehner, Kevin Lee, Phillip Jeffrey, Carsten Hopf, Antje Dittmann, Marcus Bantscheff, George Giotopoulos, Kurt R. Auger
Publikováno v:
Nature, 478(7370), 529-533. Nature Publishing Group
Recurrent chromosomal translocations involving the mixed lineage leukaemia (MLL) gene initiate aggressive forms of leukaemia, which are often refractory to conventional therapies(1). Many MLL-fusion partners are members of the super elongation comple